News & Resources

BioDuro and CTI Biotechnology Enter Strategic Partnership to Accelerate Preclinical Drug Development

IRVINE, California, April 28, 2026 – BioDuro, a trusted global Contract Research, Development and Manufacturing Organization (CRDMO), today announced a strategic partnership with CTI Biotechnology (Suzhou) Co., Ltd. ("CTI Biotechnology"), a leading provider of preclinical research services for innovative drug development. The collaboration will leverage the complementary strengths of both companies across critical stages of preclinical R&D to establish an integrated platform spanning from drug discovery to investigational new drug (IND) submission, providing global biotech and pharmaceutical clients with more efficient and flexible development solutions.
April 28, 2026
✉️Contact Us
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all